NCT06952140View on ClinicalTrials.gov

Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced Cardiomyopathy

NANot yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Sepsis Induced Cardiomyopathy
Interventions
DIETARY_SUPPLEMENT

Ketone ester

Ketone ester: 3-hydroxybutyrate as enteral bolus (500 mg/kg)

DIETARY_SUPPLEMENT

Placebo

Maltodextrin (isovolumic and isocaloric placebo) as enteral bolus

All Listed Sponsors
lead

Tor Biering-Sørensen

OTHER

NCT06952140 - Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced Cardiomyopathy | Biotech Hunter | Biotech Hunter